{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T13:42:24Z","timestamp":1694526144286},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,3,4]],"date-time":"2004-03-04T00:00:00Z","timestamp":1078358400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[2004,3]]},"abstract":"<jats:p> <jats:italic>We investigated the electrophysiological actions of dofetilide upon the ventricular myocardium to determine whether the drug modifies the inhibitory effects of subthreshold stimuli trains upon ventricular refractoriness. In nine Langendorff perfused rabbit hearts, ventricular epicardial electrodes were used to determine the following parameters at baseline and during dofetilide perfusion (0.5 micromolar): effective (ERP) and functional (FRP) refractory periods, conduction velocity (CV), wavelength (WL), and ERP prolongation (inhibitory effect) induced by subthreshold stimuli trains (STr) at pulse frequencies of 100, 300, and 600 Hz. Dofetilide significantly prolongs ventricular refractoriness and WL: ERP increment (Dofetilide\u2010baseline, 300 ms cycle length) = 33 \u00b1 20 ms (24 \u00b1 12%, P &lt; 0.01); FRP increment = 37 \u00b1 19 ms (23%\u00b1 10%, P &lt; 0.01); WL increment = 4.1 \u00b1 3.2 cm (27%\u00b1 20%, P &lt; 0.01), without modifying CV. These effects are diminished upon increasing the stimulation frequency: ERP increment (Dofetilide\u2010baseline, 150 ms cycle length) = 18 \u00b1 10 ms (18%\u00b1 12%, P &lt; 0.05); FRP increment = 15 \u00b1 4 ms (14%\u00b1 5%, P &lt; 0.01); WL increment = 1.9 \u00b1 1.7 cm (18%\u00b1 10%, P &lt; 0.01). The STr significantly prolong ERP, and the increments obtained at baseline and during dofetilide perfusion are similar. In both cases the inhibitory effect is slight for STr of 100 Hz (baseline = 5 \u00b1 3 ms, dofetilide = 6 \u00b1 5 ms, with nonsignificant (ns) differences between them) and highly manifest for STr of 300 Hz (baseline = 76 \u00b1 33 ms, dofetilide = 87 \u00b1 32 ms, ns) and 600 Hz (baseline = 109 \u00b1 39 ms, dofetilide = 89 \u00b1 34 ms, ns). Dofetilide prolongs ventricular refractoriness and WL, exerting a reverse\u2010frequency dependent effect without modifying CV. The inhibitory effect of STr is greater when their pulse frequency is increased, and its magnitude is similar under the influence of dofetilide. During dofetilide perfusion the inhibitory effect of STr adds to the ERP prolongation induced by the drug. (PACE 2004; 27:327\u2013332)<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1540-8159.2004.00436.x","type":"journal-article","created":{"date-parts":[[2004,3,4]],"date-time":"2004-03-04T09:39:52Z","timestamp":1078393192000},"page":"327-332","source":"Crossref","is-referenced-by-count":2,"title":["Dofetilide Effects on the Inhibition by Trains of Subthreshold Conditioning Stimuli"],"prefix":"10.1111","volume":"27","author":[{"given":"FRANCISCO J.","family":"CHORRO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANGEL","family":"FERRERO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JAVIER","family":"SAIZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUAN","family":"SANCHIS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUAN C.","family":"PORRES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LUIS","family":"MAINAR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOAQUIN","family":"C\u00c1NOVES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ESTRELLA","family":"BLASCO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VICENTE","family":"L\u00d3PEZ\u2010MERINO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LUIS","family":"SUCH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,3,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.37.5.534"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.68.4.707"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(86)90757-5"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(87)90495-9"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a062412"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-0736(91)90082-W"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a060211"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a060452"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199009000-00008"},{"key":"e_1_2_6_11_2","first-page":"318","article-title":"UK\u201068,798: A novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells","volume":"256","author":"Gwilt M","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_12_2","first-page":"809","article-title":"Voltage\u2010 and time\u2010dependent block of the delayed K+ current in cardiac myocytes by dofetilide","volume":"262","author":"Carmeliet E","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.21.2665"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.21.2184"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.1996.tb00594.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00506-2"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909163411201"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199424020-00003"},{"key":"e_1_2_6_19_2","first-page":"135","article-title":"Differential atrial versus ventricular activities of class III potassium channel blockers","volume":"285","author":"Baskin EP","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.1.104"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(00)00320-5"},{"key":"e_1_2_6_22_2","first-page":"100","article-title":"Inhibition in isolated human myocardium","volume":"7","author":"Windle JR","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.1999.tb00226.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2001.01176.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2001.01145.x"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8159.2004.00436.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8159.2004.00436.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1540-8159.2004.00436.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8159.2004.00436.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T09:42:04Z","timestamp":1694425324000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8159.2004.00436.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["10.1111\/j.1540-8159.2004.00436.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8159.2004.00436.x","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"value":"0147-8389","type":"print"},{"value":"1540-8159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}